Granted Patent
B2
US 7,374,932 · App. 11/025,671 · Granted May 20, 2008
Human kinases and polynucleotides encoding the same, and uses thereof
Assignee:
Lexicon Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Claims (5)
1. An isolated nucleic acid molecule comprising a nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO:2.
2. An isolated nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1.
3. A recombinant expression vector comprising the isolated nucleic acid molecule of claim 1 .
4. The recombinant expression vector of claim 3 , wherein said nucleic acid molecule comprises the nucleotide sequence of SEQ ID NO:1.
5. A host cell comprising the recombinant expression vector of claim 3 .
Assignments (4)
RELEASE OF SECURITY INTEREST
Recorded May 5, 2026
From: OXFORD FINANCE LLC
To: LEXICON PHARMACEUTICALS, INC.; LEXICON PHARMACEUTICALS
Reel/Frame 075545/0601 →
SECURITY INTEREST
Recorded Mar 17, 2022
From: LEXICON PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 059432/0709 →
RELEASE OF SECURITY INTEREST
Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST
Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →
Continuity (4)
Provisional Application
6020601500
· May 19, 2000